Literature DB >> 23263905

Predictive factors of lymph node status in small peripheral non-small cell lung cancers: tumor histology is more reliable.

Yang Zhang1, Yihua Sun, Lei Shen, Yuan Li, Jiaqing Xiang, Yawei Zhang, Hong Hu, Haiquan Chen.   

Abstract

BACKGROUND: During the past two decades, many studies have sought to find reliable predictors of N0 status in small-sized lung cancers. However, the way of tumor size measurement was usually not clearly stated, and controversy remains as to whether systematic lymph node dissection should be performed in patients with subcentimeter tumors.
METHODS: We reviewed correlations between lymph node involvement and clinicopathological variables in 243 small peripheral non-small cell lung cancers with their size measured in fresh specimens before formalin fixation. Histologic subtypes of adenocarcinomas were classified in line with the new International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) lung adenocarcinoma classification.
RESULTS: Incidence of N1 and N2 nodal involvement was 5.3 and 6.6 %, respectively. N2 disease was present in a proportion of subcentimeter tumors (2/53, 3.8 %). No lymph node metastasis was revealed in squamous cell carcinomas, adenocarcinoma in situ, minimally invasive adenocarcinoma, lepidic predominant adenocarcinoma, or invasive mucinous adenocarcinoma. Collectively, the five cell types accounted for 34.6 % of all the small peripheral cases.
CONCLUSIONS: Precise measurement of tumor size in fresh tissues revealed that tumor size was not a reliable predictor of N0 status. However, through histologic classification, systematic lymph node dissection might be avoided in more than one third of small peripheral NSCLC.

Entities:  

Mesh:

Year:  2012        PMID: 23263905     DOI: 10.1245/s10434-012-2829-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  20 in total

1.  Does less equal more? The curious issue of small-sized lung cancer.

Authors:  Katarzyna Żanowska; Jarosław Kużdżał
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

2.  Lung cancer screening in China: early-stage lung cancer and minimally invasive surgery 3.0.

Authors:  Difan Zheng; Haiquan Chen
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

3.  Recognition of "aggressive" behavior in "indolent" ground glass opacity and mixed density lesions.

Authors:  Junyan Zha; Dong Xie; Huikang Xie; Liping Zhang; Fangyu Zhou; Pengqing Ying; Lilan Zhao; Gening Jiang; Ke Fei; Chang Chen
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

4.  Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer.

Authors:  Feichao Bao; Ping Yuan; Xiaoshuai Yuan; Xiayi Lv; Zhitian Wang; Jian Hu
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

5.  Microsized lung adenocarcinoma vs. small-sized lung adenocarcinoma: clinical characteristics, advantages and surgical implications.

Authors:  Giuseppe Mangiameli; Pierfilippo Crucitti; Gaetano Rocco
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 6.  Implementing the new IASLC/ATS/ERS classification of lung adenocarcinomas: results from international and Chinese cohorts.

Authors:  Ming-Ching Lee; Kyuichi Kadota; Daniel Buitrago; David R Jones; Prasad S Adusumilli
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

7.  Histologic subtype component predicts lymph node micrometastasis and prognosis in patients with stage I lung adenocarcinoma.

Authors:  Jung-Jyh Hung
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

8.  Prognosis and status of lymph node involvement in patients with adenocarcinoma in situ and minimally invasive adenocarcinoma-a systematic literature review and pooled-data analysis.

Authors:  Long Jiang; Weiqiang Yin; Guilin Peng; Wei Wang; Jianrong Zhang; Yang Liu; Shengyi Zhong; Qihua He; Wenhua Liang; Jianxing He
Journal:  J Thorac Dis       Date:  2015-11       Impact factor: 2.895

9.  Impact of maximum standardized uptake value of non-small cell lung cancer on detecting lymph node involvement in potential stereotactic body radiotherapy candidates.

Authors:  Shanyuan Zhang; Shaolei Li; Yuquan Pei; Miao Huang; Fangliang Lu; Qingfeng Zheng; Nan Li; Yue Yang
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

10.  The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.

Authors:  Takashi Eguchi; Kyuichi Kadota; Bernard J Park; William D Travis; David R Jones; Prasad S Adusumilli
Journal:  Semin Thorac Cardiovasc Surg       Date:  2014-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.